CHRISTOPHER ANDERSON: Open Payments
NPI 1669889820 · GROTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 32 payments from 9 companies in 2025. Trend: 2023 $1,329 · 2024 $858 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $147 |
| Novo Nordisk Inc | 7 | $141 |
| Stryker Corporation | 2 | $96 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| ALK-Abello, Inc | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Organogenesis Inc. | 1 | $19 |
Products named: VRAYLAR, Ozempic, Rybelsus, ARTIX MT, CLOTTRIEVER BOLD CATHETER, VOQUEZNA, NEFFY, FANAPT.
Industry payments across CT — which companies pay providers there.
